Movement Performance in Persons With Chronic Back Pain
Acute Effects of Spinal Manipulative Therapy, Exercise Therapy and Open-label Placebo on Movement Performance in Individuals With Chronic Back Pain
1 other identifier
interventional
40
1 country
1
Brief Summary
The goal of this laboratory-based cross-over randomized controlled study is to study the immediate effects Spinal manipulative therapy (SMT) and exercise therapy (ET) compared to open-label placebo (OLP) on movement performance, gait, active trunk mobility and pain-intensity in persons with chronic non-specific back pain. The main question this study aims to answer is: What are the immediate and measurable effects of SMT and ET on work movements, gait, active trunk mobility and pain-intensity in people with chronic non-specific back pain, compared with and in combination with open-label placebo treatment (OP)? The investigators hypothesize that the participants, after SMT and ET, will perform the lifting task faster, and use more range of motion in most of the joints. They also believe that a greater range of motion is used during gait and that the active ROM in the back is increased, while the pain intensity scores decrease after these interventions. The investigators hypothesize that the control intervention (OLP) could be effective as an add-on intervention, but not as a single intervention. All participants will receive all three interventions SMT, ET and OLP and to study the immediate effects, the participants will be asked:
- to lift a box with two different weights
- to walk straight forward with and without a cognitive dual task
- perform two clinical tests of active range of motion (
- rate the intensity of their pain "right now"
- rank the treatment effects of these three treatment methods
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 6, 2025
CompletedFirst Posted
Study publicly available on registry
March 24, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2026
ExpectedJuly 14, 2025
July 1, 2025
4 months
March 6, 2025
July 9, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Lifting performance
Participants are asked to perform the movement at a comfortable self-selected speed. They perform two consecutive lifts and between the lifts, the test staff will the object to its original position. To standardize the test, the height of the table is adjusted to 50% of the participant's body height and the horizontal distance between the participant and the table to 75% of his/her arm length. The lift is performed in two situations: one "light" situation and one "moderate/heavy" situation. Kinematic and kinetic variables defining movement performance during the lifting task will be used to analyze the data. The lifts will be divided into two phases: a downward and an upward phase, and expressed in % movement-time. For each phase, we will study variables such as fixed time, speed of movement, ROM, intersegmental coordination.
Immediately after each intervention, the participants perform the lifting task. The results will be compared to the baseline measures.
Secondary Outcomes (7)
Gait - 1) Temporal gait parameters
Immediately after each intervention, the participants perform the gait task. The results will be compared to the baseline measures.
Gait - 2) Spatial gait parameters
Immediately after each intervention, the participants perform the gait task. The results will be compared to the baseline measures.
Gait - 3) Joint angles during gait
Immediately after each intervention, the participants perform the gait task. The results will be compared to the baseline measures.
m-FTF
Immediately after each intervention, the participants perform the test of active range of motion. The results will be compared to the baseline measures.
mm-Schober's test
Immediately after each intervention, the participants perform the test of active range of motion. The results will be compared to the baseline measures.
- +2 more secondary outcomes
Study Arms (3)
Spinal manipulation therapy (SMT)
EXPERIMENTALChiropractic treatment
Exercise Therapy (ET)
EXPERIMENTALPhysical therapy treatment
Open Placebo (OLP)
PLACEBO COMPARATOROpen-label treatment
Interventions
In the present study, a short examination of the whole spine and pelvic area will be performed to identify those segments with the highest restricted range of motion compared to other parts. A standard HVLA manipulation of this area is applied, which refers to Maitland grade 5.
In the present study, the participant will, after short warming up, perform three standard exercises aiming to increase the possibility for a person with back pain to control the full range of spinal, pelvis and hip joints (Exercise 1) to increase the motor control and coordination of the muscles controlling the low back, pelvis and hip joints in flexion and rotation (Exercise 2), and to increase the motor control of muscles controlling the low back, pelvis and hip joints in extension (Exercise 3).
In the present study, the procedure will follow the study of Carvalho, et al. (2016).28 The researcher explains clearly in a positive way to the participants that i) a placebo effect can be powerful, ii) the body can automatically respond to taking placebo pills like Pavlov's dogs that salivated when they heard a clock, iii) that a positive attitude can be helpful, but is not necessary, and iiii) the researcher shows a short video clip (1 minute 25 seconds) of a news report, where participants in an OLP study are interviewed on the positive effects they experienced (https://www.youtube.com/watch?v=Jp14Lhl0T9). Thereafter, the participants are asked to take two pills, containing the inactive substance microcrystalline cellulose from a container clearly labeled with "placebo".
Eligibility Criteria
You may qualify if:
- Persons who have either experienced continuous or recurring back pain for a period longer than 3 months). Back pain is defined as problems/discomfort from the spine Th1-S1 with associated costovertebral joints and sacroiliac joints, thus including both the lumbar spine and the thoracic spine. The area of pain extends from Th1 to the inferior gluteal fold but does not include the shoulder blades
- \>18 years old,
- those who can speak and understand Scandinavian or English.
You may not qualify if:
- "red flags"
- persons with specific back problems, rheumatic inflammatory joint- and/or back diseases, fractures, diagnosed hip osteoarthritis, fibromyalgia, or neurological co-morbidity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- Stiftelsen Rönnbäretcollaborator
Study Sites (1)
Karolinska Institutet
Huddinge, 141 83, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- University lecturer
Study Record Dates
First Submitted
March 6, 2025
First Posted
March 24, 2025
Study Start
September 1, 2025
Primary Completion
December 30, 2025
Study Completion (Estimated)
September 30, 2026
Last Updated
July 14, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
- Time Frame
- 10 years after publication
- Access Criteria
- Researcher or university
All data will be coded making it impossible to identify individuals. On request, this coded data can be shared.